Inventor · disambiguated record
Bernard J. Van Vliet
Also filed as: VAN VLIET BERNARD J · VLIET BERNARD J VAN
11 granted patents·6 pending applications·98 citations·filing 1999–2011
86Inventor score
Top patents by PatentIndex Score
17 records- 0192US6476060B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2001·Granted Nov 5, 2002·78 cites·24 claims
- 0276US7786144B2Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonistsSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·2 cites·13 claims
- 0370US7678789B2[1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particularSOLVAY PHARM BV·Filed 2006·Granted Mar 16, 2010·1 cites·6 claims
- 0468US8101619B2Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibitionFEENSTRA ROELOF W·Filed 2005·Granted Jan 24, 2012·2 cites·8 claims
- 0567US7067513B1PhenylpiperazinesSOLVAY PHARM BV·Filed 2000·Granted Jun 27, 2006·3 cites·7 claims
- 0662US7605162B2PhenylpiperazineSOLVAY PHARM BV·Filed 2008·Granted Oct 20, 2009·0 cites·6 claims
- 0758US7928134B25-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonistsSOLVAY PHARM BV·Filed 2008·Granted Apr 19, 2011·0 cites·11 claims
- 0856US7456182B2PhenylpiperazinesSOLVAY PHARMACEUTICALS INC·Filed 2006·Granted Nov 25, 2008·0 cites·6 claims
- 0954US6391896B13-Tetrahydropyridin-4-yl indoles for treatment of psychotic disordersDUPHAR INT RES·Filed 1999·Granted May 21, 2002·12 cites·7 claims
- 1051US2006166969A1AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorderTURSKI LECHOSLAW A·Filed 2006·Application pending·0 cites
- 1145US2011160459A15-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonistsSOLVAY PHARM BV·Filed 2011·Application pending·0 cites
- 1244US8937184B21H-imidazole derivatives as cannabinoid CB2 receptor modulatorsLANGE JOSEPHUS H M·Filed 2006·Granted Jan 20, 2015·0 cites·8 claims
- 1343US2007142362A14,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulatorsSOLVAY PHARM BV·Filed 2006·Application pending·0 cites
- 1442US2011053983A1(5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activityLANGE JOSEPHUS H M·Filed 2009·Application pending·0 cites
- 1542US2006194971A1Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmissionDRUKARCH BENJAMIN·Filed 2006·Application pending·0 cites
- 1642US2007142397A2Phenypiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibitionSOLVAY PHARMECEUTICALS B V·Filed 2005·Application pending·0 cites
- 1737US8410135B24,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulatorsLANGE JOSEPHUS H M·Filed 2008·Granted Apr 2, 2013·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →